MyBiotics Pharma LTD

About:

MyBiotics leverages proprietary culturing & AI technologies to develop microbiome-based products for the therapeutics and food markets

Website: https://mybiotics-pharma.com

Top Investors: EASME - EU Executive Agency for SMEs, AnGes, MII, Chaim Hurvitz

Description:

MyBiotics innovative technologies; MyCrobeTM and SuperDonorTM allow us to be in the front of the microbiome field. Both technologies resolve the three critical factors in the probiotic development market. Delivery, Targeting and Colonization. MyCrobeTM and SuperDonorTM provide single or multi-bacterial combinations for targeted treatment, whole microbiome restoration and the first actual screening method to replace FMT microbiome transplantations. MyBiotics focus is to return the bacterial population to its healthy and balanced state by using live bacteria that will colonize and compete with the existent disease-promoting population.